KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Capital Expenditures (2016 - 2024)

Historic Capital Expenditures for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q4 2024 value amounting to $26000.0.

  • Rigel Pharmaceuticals' Capital Expenditures changed N/A to $26000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $252000.0, marking a year-over-year change of. This contributed to the annual value of $36000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Rigel Pharmaceuticals' Capital Expenditures is $26000.0.
  • Rigel Pharmaceuticals' Capital Expenditures' 5-year high stood at $607000.0 during Q1 2020, with a 5-year trough of -$44000.0 in Q2 2020.
  • In the last 4 years, Rigel Pharmaceuticals' Capital Expenditures had a median value of $170000.0 in 2021 and averaged $181923.1.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Capital Expenditures crashed by 13826.09% in 2020 and then soared by 102500.0% in 2021.
  • Quarter analysis of 4 years shows Rigel Pharmaceuticals' Capital Expenditures stood at $504000.0 in 2020, then tumbled by 104.17% to -$21000.0 in 2021, then skyrocketed by 447.62% to $73000.0 in 2022, then plummeted by 64.38% to $26000.0 in 2024.
  • Its Capital Expenditures stands at $26000.0 for Q4 2024, versus $73000.0 for Q4 2022 and $189000.0 for Q3 2022.